At a glance
ClinicalIndex Comparison RecordN/ACompleted· 1 enrolled
Drug / intervention
Biobridge and lymph node transferdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Prospective Evaluation of a Surgical Solution for Breast Cancer-Associated Lymphedema
In Brief
A clinical study evaluating Biobridge and lymph node transfer for Lymphedema and Edema. Completed, enrolled 1 participant across 1 site.
Detailed Summary
To investigate whether addition of the Biobridge scaffold to the standard surgery for vascularized lymph node transfer will improve the outcome of surgical treatment in lymphedema of the upper arm.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsLymphedema, Edema
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedApr 2016
Enrollment StartJul 2016
Primary CompletionJul 2018
Study CompletionOct 2020
TodayJul 2026
First PostedApr 12, 2016
Enrollment StartJul 20, 2016
Primary CompletionJul 7, 2018
Study CompletionOct 29, 2020
TodayJul 2, 2026
Enrollment to primary: 2.0 yearsPosted 10.2 years ago
Interventions
Biobridge and lymph node transferdevice
Biobridge is surgically implanted with conventional vascularized lymph node transfer surgery